Home > Onderwijs > Masteropleidingen > Opleidingen [a-z] > [c-d] > Drug Discovery and Safety

Drug Discovery and Safety (DDS)

Broaden your perspective on human disease and medicine

From the characterization of molecular causes of pathology to a generation of new therapeutics to treat diseases, from small molecules and proteins to diseases and medicines. If you are fascinated by the idea of developing new pharmacological therapies, then this is the Master’s programme for you.

Challenging and relevant for society
In the Master’s programme in Drug Discovery and Safety, you will examine the interaction between molecules and the human body from a range of perspectives: chemical, medical, toxicological, pharmacological and genetic. You will focus on a specialization that suits your specific interests while working in a multidisciplinary environment where you  ill be challenged to address key questions about the medicines of the future. Sixty per cent of diseases are still incurable, so there are still a great many challenges for researchers to tackle.

  • Taal: Engels
  • Duur: 2 years
  • Collegegeld:

    Tuition fees.    

  • Aanmelden voor: 1 April for non-EU/EEA students; 1 April for EU and EEA students; 1 June for Dutch students from institutions other than VU University Amsterdam; 1 December for second start date 1 February (Dutch students only)
  • Startdatum: 1 September
    1 February
  • Vorm: Voltijd
  • Interessegebied: Gezondheid en Beweging, Natuurwetenschappen
  • Specialisaties:

    Biomarkers and Clinical Chemical Analysis
    Computational Medicinal Chemistry and Toxicology
    Drug Design and Synthesis
    Drug Discovery and Target Finding
    Drug Disposition and Safety Assessment

  • Toelatingseisen:

    Admission requirements.

Azra Delic"After my major research project at the Department of Chemistry and Pharmaceutical Sciences, I wanted to experience how it is to perform research in the pharmaceutical industry. So I did some browsing on the internet and I found that Boehringer Ingelheim has a Research and Development branch in Vienna (Austria). This R&D site focuses on oncology research, my main interest. The Division of Medicinal Chemistry has contacts with Boehringer Ingelheim, which made it easy to approach them." read more >>
Azra Delic, Master's student Drug Discovery and Safety



© Copyright Vrije Universiteit Amsterdam
See also
Apply online